Background: Patients want to be more involved in medical decision-making. To this end, some decision aids are now available.
P
eople have a right and an ethics-based entitlement to self-determination. They want to be involved in health-and disease-related decisions (1) . This is especially relevant for measures that are aimed at healthy people (for example, screening tests for early detection of cancer), for measures with a dubious balance of benefit-to-harm, and for chronic diseases with an uncertain course, such as cancer or multiple sclerosis (MS).
Decisions that are made jointly by patients and physician are referred to as shared decision making (SDM) (2) . Support for weighing the options in an individualized manner is given by decision aids (3) and evidencebased patient information (EBPI) (4) .
This study aims to provide a descriptive overview of international and German decision aids as well as providers of decision aids in Germany. The concept of decision aid is discussed in the context of EBPI and SDM. Key aspects of the development, evaluation, and implementation are presented and exemplified using decision aid tools for MS.
An eAppendix with further information about quality criteria and decision aids (in German) is available on our homepage: www.chemie.uni-hamburg.de/igtw/Ge sundheit/publikationen/pub_lenz.html
Shared decision making
There is no uniform definition of SDM (5) . SDM represents a certain style of communication between patients and health professionals and takes place when the people involved in making the decision exchange relevant information in order to jointly make and implement a decision (6) . According to the basic idea of evidence-based medicine (7), SDM should be based on reliable EBPI and take into consideration the participant's individual attitude.
Decision aids
Decision aids address preventive, diagnostic, and therapeutic measures and should help to balance individual options (3, 8) . Their purpose is not to advise for specific measures or to increase treatment adherence. Decision aids are available as brochures, videos, web programs, or decision tables, and they incorporate various goals and teaching strategies (9) . For example, supplying relevant information should motivate patients to reflect on their own attitudes and, consequently, to participate in decision-making. Conversely, motivating patients to think about their own values can represent an entry point into an information process that encourages patients to participate in SDM.
Decision aid development is complex and usually includes a variety of theoretical and empirical groundwork (10) . Since the use of decision aids can impact patient care (3), a thorough evaluation of their effectiveness through randomized controlled trials (RCTs) is required prior to their implementation.
Various tools are available to evaluate the quality of decision aids (8) , including the International Patient Decision Aid Standards (IPDAS) Collaboration assessment checklist IPDASi (IPDAS instrument) (14) , the instrument MATRIX to evaluate the development and evaluation processes of decision aids (9) , and the instrument EQIP (Ensuring Quality Information for Patients) to evaluate information quality (15) .
Evidence-based patient information
EBPI is a key component of decision aids, and internationally defined quality criteria are available (4, 11, 12) . Ethical guidelines (13) clarify what content and meta-information for patients is relevant, and include
• information about the natural course of the disease (e.g., symptoms and prognosis of the disease without intervention);
• a comprehensive list of all options, which includes the possibility of (initially) refraining from intervention;
• the probability of success of, failure of, and harm from the upcoming medical interventions;
• patient-relevant outcomes;
• lack of evidence; • data about possible false-positive and falsenegative results for diagnostic measures. EBPI should be easily understandable for the general public and presented in an unbiased manner. For some of the presented criteria, good evidence with respect to cognitive endpoints is lacking (Box 1). Developing health information requires that target group representatives are involved in the development process (4) .
Developing EBPI is time-consuming and complex. Ensuring quality information requires, among other things, systematic searches for medical and scientific literature (for example, searching for the clinical picture of a disease, available options and their effectiveness) and a critical appraisal of these. Updating EBPI content is important, especially considering the current short half-life of scientific information.
Inventory

Methods
To identify non-German decision aids, database searches of the current Cochrane reviews (3) were supplemented with searches of MEDLINE (Ovid), EMBASE (Ovid) and PsycInfo (Ovid) up to August 2011 (eAppendix; available on our homepage [in German]). Decision aids were included if they met the Cochrane criteria and had been tested for effectiveness in RCTs.
To identify German decision aids, the term "patient information" was added to the search strategy and the language was limited to German (eAppendix). Known publications and reference lists of identified studies were searched for additional publications. Only those German decision aids were included in the study that met the Cochrane criteria and had been evaluated in RCTs.
A systematic database search was considered to be not appropriate for determining which providers are usually identified by lay people on the internet; instead, a Google search was done for the German terms "Entscheidungshilfe" (decision support) AND "Patient" (patient), and "evidenzbasiert" (evidence-based) AND "Patienteninformation" (patient information). The first 100 hits were screened for providers. Moreover, websites of known providers were screened for decision aids or EBPI as well as for links to other providers. Identified providers were assigned to one of three categories ( Table 1) . BOX 1 Criteria for evidence-based patient information (4)
• Criteria with good evidence for the cognitive end points knowledge, risk perception, comprehension, understanding: -Numerical representation of numbers and results: absolute risk reduction, statistics in natural frequencies rather than in percentages, specified benchmarks -Linguistic representation of risks: no linguistic representation of risk (using words such as seldom, often, etc.) without giving additional numerical data -Graphical representation of data: pictographs, bar charts, and pie charts
• Examples of relevant criteria, for which there is currently no good evidence regarding cognitive endpoints:
As long as no evidence exists, target groups should provide feedback about how to implement these criteria: -Pictures and Drawings: illustrations of the text information -Narrative: patient reports and stories -Cultural characteristics: for patient information, the only approach to implementing this criterion is through oral communication -Layout issues: adjustment of font size, font type, contrast between background and font, and format, with respect to the target group -Language: easily understandable by the general public and specific for the target group; should promote participation
Results
International decision aids tested for efficacy
From the recent Cochrane review (3), 82 RCTs for nonGerman decision aids were initially extracted. From our own database research over the period January 2009 to August 2011, we identified and assessed 3693 titles and 54 publications (with full texts). Of these, we included 24 publications that covered 20 decision aids, and excluded 30 that did not contain a RCT or that evaluated a decision aid that did not meet the Cochrane criteria. In addition to the RCTs included in the current Cochrane review, we identified 106 RCTs for nonGerman decision aids (additional figures and tables are available [in German] on our homepage).
Decision aids address a variety of preventive, diagnostic and therapeutic options (3) and are to be used individually or as components of SDM programs. Additionally, consultations with physicians and health care professionals often take place. The main evaluation parameters considered knowledge, attitude, decisions taken, informed choice, decision confidence, patient satisfaction with respect to the decision, and patient preferences.
German decision aids tested for effectiveness
Of the 391 titles identified, we tested 339 and evaluated 19 based on their full texts. A total of 12 RCTs of 10 German decision aids were included ( Table 2) ; seven of Providers of decision aids and patient information in Germany
This table is not meant to be exhaustive but rather to reflect an internet search with the search engine Google; the terms "Entscheidungshilfe" (decision support) AND "Patient" (patient), and "evidenzbasiert" (evidence-based) AND "Patienteninformation" (patient information), were entered, and the first 100 hits were screened. * 2 Information was labeled by provider as "EBPI" * 3 Material was referred to by the provider as decision aid * 4 Evidence base is not reported by the providers, but "evidence-based" was claimed to be a feature, e.g. in the provider`s quality standard "Evidence-based health information" on various topics/areas (e.g., heart and circulatory system, immune system and infections, children and family, head and nerves, cancer, muscles, bones and joints, kidneys and urinary tract, and surgery and prevention). Indication-specific EBPI for the patient to fill out with information provided
Patient information for chronic obstructive pulmonary disease (COPD) and asthma
Succinct information for patients with selected diseases such as cancer, heart attack, stroke, or respiratory disease
Health information on various topics (e.g., hormone treatment, colon cancer screening, mammography, cervical cancer screening, HPV vaccine and multiple sclerosis, prevention of osteoporosis, and pain management during surgery)
Decision aids on various topics (e.g., breast cancer, colon cancer, cervical cancer, cardiovascular disease, depression, dementia, and vaccinations)
Evidence-based decision aids (prevention of heart attacks and multiple sclerosis) the full-text publications were excluded because they did not contain RCTs or did not evaluate a decision aid. Four of the 12 RCTs that we included are also in the current Cochrane review. In addition to indication-specific clinical endpoints, we also evaluated knowledge, treatment adherence, patient satisfaction, patient participation in decisionmaking, autonomy preferences, and decision conflict as parameters for results. RCT validity was not assessed here (additional figures and tables are available [in German] on our homepage).
Providers of decision aids in German
We identified several German providers of decision aids ( Table 1) , as well as providers of patient guidelines or patient information, who based their content on guidelines from scientific medical societies (for example, the German Society of General Practice and Family Medicine [Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin). We even identified internet sites which did not directly provide information but rather gave links to providers, decision aids, and EBPI (for example, the German Network for Evidence-Based Medicine [Deutsches Netzwerk evidenzbasierte Medizin] and the German Cochrane Centre [Deutsches Cochrrance Zentrum]). However, it was not possible for most providers to determine to which extent information is actually evidencebased. 2) . The decision aid on immunotherapy is composed of a detailed information brochure and a decision worksheet. In addition to the detailed information brochure (e1), a second decision aid for MS relapse management is provided through a four hour group training, discussion and reflection for patients with MS and their relatives (16) . Relapse management faces several uncertainties and is prototypical for the use of decision aids, since relapses can differ greatly and have unclear prognostic significance (e2). Guidelines recommend a short-term, high-dose intravenous therapy with glucocorticoids (e3), yet this is based on weak evidence: Only short-term effects have been demonstrated (with no apparent long-term benefit of administering oral glucocorticoids over placebos), and adverse effects are common and can be severe (e2).
Development
Since no evidence-based decision aids were available (17) , decision aids were developed based on several preliminary studies. The decision aids should help people with MS to recognize that, in the event of a relapse, they have several possible choices, including the option of waiting. People with MS were involved in all stages of development. Two people conducted the training: a nurse and one person with MS.
RCTs revealed that fewer relapses occurred following intervention with intravenous therapy (22% rate of relapses in the intervention group) as compared to the control group (44%, p<0.0001), and that patients receiving the intervention had increased knowledge of risk and were more autonomous in their decisionmaking (16) .
In the subsequent implementation study (e4), 31 participants were trained in a train-the-trainer program to provide the decision aids at various centers across Germany. The results of 261 participants with MS demonstrated that the program could be put into practice, but with different implementation barriers.
At present, the program is solidly implemented at two rehabilitation centers for people with MS, the UKE outpatient clinic and a self-help organization. The program was transferred to a Canadian center at the end of 2011 (additional figures and tables are available [in German] on our homepage.) German-language decision aids with proven effectiveness No.
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Discussion
The authors identified several internet sites that offer a variety of information which is labeled as evidencebased patient information or decision aid. However, whether the content is indeed evidence-based is often difficult to determine. Patients who search the internet for decision aids are likely to use terms for their individual indications, such as "diabetes" or "heart attack." Although this review does not address indication-specific searching, the lack of clarity in our obtained search results is likely to be similar to that of indication-specific searches.
The copious amount and variety of available information contrasts starkly with the absence of highquality decision aids. A yet unresolved problem is the non-transparency of information quality. Even when patient information and decision aids are labeled as "evidence-based, " the content and presentation of information is often not evidence-based (18) . Different quality seals, such as "Health on the Net" (HON) (e5) or DISCERN (e6), should demonstrate that the information is reliable. In Germany, for example, the HON seal is used on patient information sites from the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG), the German Medical Association (Bundes ärztekammer, BÄK), and the National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung, KBV) ( Table 1) . However, central EBPI quality aspects such as scientific accuracy, completeness, and content presentation are not taken sufficiently into consideration by the quality seal (19) . Users currently have little opportunity to assess the reliability of the information available.
Much of what is labeled as decision aid is freely available through the internet. However, our database searches revealed that relatively few decision aids have been evaluated for benefit and harm in RCTs. On the other hand, there are good examples of Germanlanguage decision aids that have been systematically developed and have been proven to be effective (Table 2 ).
It is difficult to draw a clear conceptual distinction between EBPI and decision aids. If an EBPI is designed to be used for decision-making, it basicaly satisfies the IPDAS-criteria (8) . Additionally, EBPI can function alone, as exemplified by the "drug facts box" (e7), in which the benefits and adverse effects of a drug are directly compared using absolute risks. In fact, a RCT demonstrated that a drug facts box, as compared to standard information, improved knowledge about benefits and adverse effects of a drug and may help to correct unrealistic expectations about their effectiveness (e7).
Prior to implementing a decision aid, its effectiveness should be tested in a RCT. To evaluate how a decision aid works under certain conditions, it is usually necessary to conduct additional theoretical work and empirical preliminary studies. Systematical retrieval of all available trial publications is a methodological problem (20) . One proposal for overcoming this is to develop specifically structured literature databases that allow complete identification, which would facilitate quality assessment (21, 22) . An additional problem is obtaining a critical appraisal of identified literature. On the one hand, the published works are methodologically heterogeneous, which requires that the assessor has a broad methodological knowledge. On the other hand, the conditions (contextual factors) under which the decision aids were developed and/or evaluated are not always transparent. In these cases, whether a decision aid will be successful or counterproductive for users under the user's terms and conditions remains an open question.
Whether using a decision aid is helpful for a patient to reach a decision can depend on several factors. A basic requirement is that patients understand the contents, and this must be verified. In this context, health care professionals such as breast-care nurses or diabetes educators could play stronger roles (1). Additionally, successful implementation appears to require that doctors and medical staff are trained in evidence-based medicine and SDM, among other things (23, e6) .
The work presented here is not a systematic review but rather an inventory of compiled literature, which was not systematically analyzed. A systematic review No.
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P: 12 hospital wards for psychiatric acute patients, patients with schizophrenia (n = 107) I: decision aids and medical consultation (SDM); C: standard treatment; R: knowledge, the patient's wish to be involved in the decision making process (API), attitudes toward treatment options (DAI), patient involvement (COM-RADE), satisfaction (ZUF8); doctors and nurses completed additional patient-related questionnaires was published by the Cochrane Collaboration (3). It was updated in October 2011 but only contains research until December 2009. In contrast to the Cochrane review, the present work reflects various aspects of the development, evaluation and implementation of decision aids, foremost in Germany.
Summary
People want to have access to complete, unbiased and comprehensive evidence-based information, and indeed they have a right and an ethics-based entitlement to this; however, this need is currently inadequately met. Structures have to be developed that allow highquality decision aids and evidence-based patient information to be sustainably developed, evaluated and implemented. This is especially urgent for cancer and other chronic diseases.
Quality criteria for decision aids should be developed, catalogued, and validated. These criteria should go beyond IPDAS criteria and take into consideration whether contents are evidence-based as well as the transparency of the development, implementation and evaluation of the contents. Currently, guidelines are being developed for health information providers, which should improve the quality of information in the long term (24) .
To make German indication-specific decision aids available, it will be necessary to create an independent and publically-available database where authors could provide current decision aids and meta-information. In addition to available evidence about development and evaluation, this database should include quality information about whether the contents are evident-based and about the implementation conditions.
